BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2
323 results:

  • 1. Construction of a prognostic model for autophagy in Wilm's tumor.
    Shi H; Zhang M; Zhang Y
    Pediatr Surg Int; 2024 May; 40(1):122. PubMed ID: 38704513
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in Breast Cancer: A Randomized Clinical Study.
    Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment of a Novel Cancer-Specific Anti-her2 Monoclonal Antibody H
    Kaneko MK; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):35-43. PubMed ID: 38563783
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [A Long-Term Survival Case of her2-Positive Gastric Cancer with Distant Lymph Node Metastasis Receiving Multidisciplinary Therapy].
    Yasuoka S; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1816-1818. PubMed ID: 38303217
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 6. First-in-Human Evaluation of Site-Specifically Labeled
    Yeh R; O'Donoghue JA; Jayaprakasam VS; Mauguen A; Min R; Park S; Brockway JP; Bromberg JF; Zhi WI; Robson ME; Sanford R; Modi S; Agnew BJ; Lyashchenko SK; Lewis JS; Ulaner GA; Zeglis BM
    J Nucl Med; 2024 Mar; 65(3):386-393. PubMed ID: 38272704
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hsa_circ_0086414/transducer of erbb2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.
    Meng X; Li W; Yu T; Lu F; Wang C; Yuan H; Yang W; Dong W; Xiao W; Zhang X
    Int J Biol Macromol; 2024 Mar; 261(Pt 1):129636. PubMed ID: 38272402
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [
    Zhang M; Kang F; Xing T; Wang J; Ma T; Li G; Quan Z; Yang W; Chen X; Wang J
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1713-1724. PubMed ID: 38216779
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A rare case of extrarenal Wilms tumor of the uterine corpus: comprehensive genomic profile and review of the literature.
    Alessandrini L; Guerriero A; Munari G; Del Forno B; Santoro L; Marchetti M; Nardin M; Tozzi R; Fassan M; Dei Tos AP
    Pathologica; 2023 Dec; 115(6):333-340. PubMed ID: 38180141
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience.
    Hong YW; Kuo IM; Kuo WL; Yu CC; Shen SC; Tsai HP; Chu CH; Ho HY; Lo YF; Chen SC; Lin YC; Chien CY; Chou HH
    Breast Cancer; 2024 Mar; 31(2):252-262. PubMed ID: 38150135
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Role of Transcription Factors in the Loss of Inter-Chromosomal Co-Expression for Breast Cancer Subtypes.
    Trujillo-Ortíz R; Espinal-Enríquez J; Hernández-Lemus E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139393
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Projected impact of population aging on non-communicable disease burden and costs in the Kingdom of Saudi Arabia, 2020-2030.
    Boettiger DC; Lin TK; Almansour M; Hamza MM; Alsukait R; Herbst CH; Altheyab N; Afghani A; Kattan F
    BMC Health Serv Res; 2023 Dec; 23(1):1381. PubMed ID: 38066590
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Advanced renal pelvis carcinoma patient with an erbb2 insertion mutation: a case report.
    Shang P; Lou C; Yin L; Tao C; Dong Y; Yang G; Yuan Z
    J Int Med Res; 2023 Nov; 51(11):3000605231204502. PubMed ID: 37917812
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Treatments During Pregnancy Targeting erbb2 and Outcomes of Pregnant Individuals and Newborns.
    Gougis P; Grandal B; Jochum F; Bihan K; Coussy F; Barraud S; Asselain B; Dumas E; Sebbag C; Hotton J; Spaggiari E; Pierga JY; Savarino R; Laas E; Spano JP; Reyal F; Hamy AS
    JAMA Netw Open; 2023 Oct; 6(10):e2339934. PubMed ID: 37883083
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Phase I clinical evaluation of
    Bragina O; Chernov V; Larkina M; Rybina A; Zelchan R; Garbukov E; Oroujeni M; Loftenius A; Orlova A; Sörensen J; Frejd FY; Tolmachev V
    Theranostics; 2023; 13(14):4858-4871. PubMed ID: 37771776
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Loss of
    Simpson KE; Staikos CA; Watson KL; Moorehead RA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762032
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
    Cytryn SL; Moy RH; Cowzer D; Shah RH; Chou JF; Joshi SS; Ku GY; Maron SB; Desai A; Yang J; Sugarman R; Rao D; Goldberg Z; Charalambous C; Lapshina M; Antoine A; Socolow F; Trivedi N; Capanu M; Gerdes H; Schattner MA; Simmons M; Lacouture ME; Paroder V; Tang LH; Shia J; Ilson DH; Solit DB; Berger MF; Janjigian YY
    Lancet Oncol; 2023 Oct; 24(10):1073-1082. PubMed ID: 37666264
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology.
    Kobayashi G; Hayashi T; Sentani K; Uraoka N; Fukui T; Kido A; Katsuya N; Ishikawa A; Babasaki T; Sekino Y; Nose H; Hinata N; Oue N
    Pathol Int; 2023 Sep; 73(9):444-455. PubMed ID: 37589430
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cost-effectiveness of Trastuzumab Deruxtecan for her2-low Advanced Breast Cancer in the United States.
    Peng Y; Wang L; Peng L; Liu Q; Yi L; Luo X; Li S; Qin S; Wan X; Tan C; Chen G
    Clin Ther; 2023 Oct; 45(10):965-972. PubMed ID: 37537015
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
    Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
    Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.